Rapid and Ultrasensitive CRISPR-SERS Biosensing of Circulating Tumor Cell mRNAs for Molecular Metastatic Risk Assessment
Rapid and Ultrasensitive CRISPR-SERS Biosensing of Circulating Tumor Cell mRNAs for Molecular Metastatic Risk Assessment
原文摘要
出版方登记 · CrossrefMetastatic recurrence remains a major cause of poor prognosis in hepatocellular carcinoma (HCC), yet sensitive molecular assessment of metastatic risk is still limited. Circulating tumor cell (CTC)-derived transcripts offer a direct readout of tumor dissemination programs, but their rapid multiplex analysis remains challenging because of low-input rare-cell samples, low transcript abundance, and handling-associated molecular loss. Here, we report the Flexible LAMP-assisted Raman-CRISPR Engine for CTC mRNA analysis (FLARE-CTC) for multiplex transcript profiling and molecular metastatic risk assessment in HCC. Built on a flexible hierarchical surface-enhanced Raman scattering interface fabricated by a reverse-assembly peel-off transfer process, FLARE-CTC integrated rapid isothermal amplification, CRISPR-Cas12a recognition, and single-stranded DNA linker-mediated Raman-active nanoprobes to establish an anchoring-to-release Raman readout. Following CTC enrichment and on-chip lysis, this design enabled parallel quantification of seven HCC CTC-associated transcripts and β-actin within 30 min at attomolar-level sensitivity. In 58 clinical samples, integrated HCC identity-related transcripts distinguished HCC patients from healthy controls with an AUC of 0.972. Further integration of epithelial-mesenchymal transition- and stemness-associated transcripts generated a metastasis score that assessed metastatic risk with an AUC of 0.892, sensitivity of 0.947, and specificity of 0.857. A two-dimensional risk map combining diagnostic and metastatic scores further visualized patient-level molecular heterogeneity and identified imaging-negative individuals with high-risk molecular profiles. Overall, FLARE-CTC provides a rapid, ultrasensitive, and scalable biosensing strategy for multiplex CTC mRNA analysis and molecular metastatic risk assessment in HCC.
页面未能读取全文,以上为出版方登记的摘要;方法与图表见原文
来源:Analytical Chemistry · doi.org